| 1.
|
Apply knowledge of bone, lung, and genitourinary system anatomy and
physiology to nuclear medicine imaging indications and procedures. (I,
X, XVII)
|
| 2.
|
Describe characteristics and causes of common bone, lung and
genitourinary pathologies and related potential treatments. (II, XI,
XVIII)
|
| 3.
|
Describe the radiopharmaceuticals used for bone, lung and
genitourinary imaging including their physical and chemical
properties, biorouting, route and method of administration, and
advantages and disadvantages of each agent. (III, XII, XIII, XIV, XIX,
XX, XXI, XXII, XXIII, XXIV)
|
| 4.
|
Specify the dose range for bone, lung and genitourinary imaging agents
and the resulting radiation dose to various organs and tissues. (III,
XII, XIX, XXI, XXII, XXIII)
|
| 5.
|
Discuss kit and dose preparation and any special precautions to assure
the quality of bone, lung and genitourinary agents. (III, XII, XIX)
|
| 6.
|
Discuss any physical or pathological conditions or medications that
would interfere or contraindicate bone, lung or genitourinary imaging.
(IV, XII, XIX, XX, XXI, XXII, XXIII, XXIV)
|
| 7.
|
Describe patient preparation for a bone, lung and genitourinary scan.
(V, XII, XIX, XX, XXI, XXII, XXIII, XXIV)
|
| 8.
|
List the indications for bone, lung and genitourinary scans. (VI, XII,
XIII, XIV, XVI, XIX, XX, XXI, XXII, XXIII, XXIV)
|
| 9.
|
Discuss why nuclear medicine study would be preferable to or
complement other diagnostic modalities in various cases. (VI, XII,
XIII, XIV, XVI, XIX, XX, XXI, XXII, XXIII, XXIV)
|
| 10.
|
Describe the procedures for routine static planar and whole body bone
imaging and renal perfusion imaging including equipment, protocols,
dose and administration technique, administration-to-acquisition
times, acquisition parameters, standard positioning and views, special
imaging adaptations, image formatting and potential pitfalls. (VI,
XIX, XX, XXI, XXII, XXIII, XXIV)
|
| 11.
|
Discuss the indications for a 3-phase, 4-phase, and SPECT bone scan
including why a nuclear medicine study would be preferable to, or
complement other diagnostic modalities. (VII, VIII)
|
| 12.
|
Describe the protocols for a 3-phase, 4-phase, and SPECT bone imaging
including equipment, protocols, dose and administration technique,
administration-to-acquisition times, acquisition parameters, standard
positioning and views, special imaging adaptations, imaging formatting
and potential pitfalls. (VII, VIII)
|
| 13.
|
Recognize normal distribution, normal variants and various artifacts
seen on bone, lung and genitourinary imaging, and on printed images.
(IX, XII, XII, XIV, XVI, XIX, XX, XXI, XXII, XXIII, XIV)
|
| 14.
|
Identify structures on bone images and SPECT slices. (IX)
|
| 15.
|
Recognize the appearance of various pathologies seen on bone images.
(IX)
|
| 16.
|
Discuss the diagnostic and prognostic value of bone, lung and
genitourinary imaging studies. (IX, XII, XIII, XIV, XV, XVI, XX, XXI,
XXII, XXIII, XXIV)
|
| 17.
|
Explain some common causes of false-negative and false- positive bone
studies. (IX, XIX, XX, XXII, XXIII, XXIV)
|
| 18.
|
Discuss possible adverse reactions and contraindications and
regulations associated with gas ventilation and aerosol ventilation
imaging. (XIII, XIV)
|
| 19.
|
Discuss special radiation safety considerations associated with gas
ventilation and aerosol ventilation imaging. (XIII, XIV)
|
| 20.
|
Discuss advantages and disadvantages associated with
ventilation/perfusion and perfusion/ventilation sequences. (XV)
|
| 21.
|
Describe the interpretive criteria for the ventilation/perfusion study
including the probability table for pulmonary embolism. (XV)
|
| 22.
|
Discuss the relationship between renal activity and aldosterone,
renin-angiotensin and ADH. (XVII)
|
| 23.
|
Describe the effects of diuretics on renal function. (XVII)
|
| 24.
|
Discuss factors that contribute to success or failure of transplanted
kidneys. (XVII)
|
| 25.
|
Describe the interventional procedures that may be used for performing
renograms. (XX)
|
|